Dec 11 (Reuters) - The U.S. Food and Drug Administration said on Thursday it has expanded the use of GSK's Blujepa as an oral ...

The FDA has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants.

A growing body of research suggests that it may have protective effects that extend to other diseases.

The vaccines were found to decrease the risk of needing medical care in the first six months after vaccination by 76 percent ...

More than 1,900 people, mostly children, have been sickened by measles in the U.S. in 2025. The outbreaks are moving the ...

Health professionals are noting a surge in a norovirus called “winter vomiting disease,” which spreads through contaminated ...

On Friday, the Centers for Disease Control and Prevention’s vaccine advisory panel voted to end a recommendation that all ...

When Susan Monarez was sworn in to lead the US Centers for Disease Control and Prevention (CDC), the country’s premier public ...

By Dan Levine and Patrick Wingrove Dec 9 (Reuters) - U.S. health regulators informed senior executives at Merck, Sanofi and ...

Norovirus cases are spreading in California and nationwide. Here's what to know about what people are calling the 2025 winter ...

The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing emergency department or urgent care ...

Doctors say the controversial vote to not recommend the vaccine for all newborns is creating chaos and hurdles for parents.